Suppr超能文献

参附注射液对大鼠肝脏缺血再灌注损伤的预防作用

[Preventive effect of shenfu injection on hepatic ischemia-reperfusion injury in rats].

作者信息

Wang Dong, Zhu Ji-ye, Leng Xi-sheng

机构信息

Department of Hepatobiliary Surgery, People' s Hospital of Peking University, Beijing.

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Jun;26 Suppl:61-3.

Abstract

OBJECTIVE

To investigate the protective effects of Shenfu Injection (SI) on hepatic ischemia-reperfusion injury in rats.

METHODS

Partial liver ischemia-reperfusion model under room temperature was established in 60 rats, which were divided into the control group and the treated group randomly and each group was again classified into 3 subgroups with 30 min, 60 min and 90 min hepatic ischemia time rspectively. Rats in the treated group were injected with SI 10 ml/kg every day, while the control group treated with normal saline. Survival rate after 1 week was observed, the serum levels of aspartate aminotransferase (AST), malondialde hyde (MDA), surperoxide dismutase (SOD), tumor nicrosis factor alpha (TNF-a) and endothelin (ET) were detected, and hepatic biopsy was performed with light and electronic microscope.

RESULTS

The survival rate in the treated subgroup with 90 min' ischemia after 1 week was 90%, higher than that in the control subgroup significantly (P <0. 05), which was 60% ; and serum levels of AST, MDA, TNF-alpha and ET were lower and SOD was higher significantly (all P <0.05), as well as the degenerative and necrotic degree of hepatocyte and sinusoidal endothelial cells was lighter in the 3 treated subgroups, compared with the control group.

CONCLUSION

Shenfu injection can eliminate oxygen free radical during hepatic ishemia-reperfusion so as to has a protective effect and attenuate hepatic ischemia reperfusion injury.

摘要

目的

探讨参附注射液(SI)对大鼠肝脏缺血再灌注损伤的保护作用。

方法

将60只大鼠建立常温下部分肝脏缺血再灌注模型,随机分为对照组和治疗组,每组再分为3个亚组,肝脏缺血时间分别为30分钟、60分钟和90分钟。治疗组大鼠每天注射SI 10 ml/kg,对照组注射生理盐水。观察1周后的生存率,检测血清天冬氨酸转氨酶(AST)、丙二醛(MDA)、超氧化物歧化酶(SOD)、肿瘤坏死因子α(TNF-α)和内皮素(ET)水平,并进行肝脏光镜和电镜活检。

结果

缺血90分钟的治疗亚组1周后的生存率为90%,明显高于对照组的60%(P<0.05);治疗组3个亚组的血清AST、MDA、TNF-α和ET水平均低于对照组,SOD水平高于对照组(均P<0.05),肝细胞和肝窦内皮细胞的变性坏死程度也较对照组轻。

结论

参附注射液可在肝脏缺血再灌注过程中清除氧自由基,从而起到保护作用,减轻肝脏缺血再灌注损伤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验